Skip to main content Accessibility help
×
Home

Distinct cognitive phenotypes in Alzheimer's disease in older people

  • Emma R.L.C. Vardy (a1) (a2), Andrew H. Ford (a3), Peter Gallagher (a4), Rosie Watson (a2), Ian G. McKeith (a2), Andrew Blamire (a5) and John T. O’Brien (a2) (a6)...

Abstract

Background:

Alzheimer's disease (AD) is considered to be a disorder predominantly affecting memory. It is increasingly recognized that the cognitive profile may be heterogeneous. We hypothesized that it would be possible to define distinct “cognitive phenotypes” in older people with AD.

Methods:

Participants from three individual studies were included, consisting of 109 patients with a diagnosis of probable AD, and 91 age- and gender-matched control participants. All had demographic and cognitive assessment data available, including the Cambridge Cognitive Examination of the Elderly (CAMCOG). The CAMCOG scores and sub-scores were further analyzed using hierarchical cluster analysis and factor analysis.

Results:

Three clusters were identified. The scores loaded onto three factors representing the domains of attention, praxis, calculation, and perception; memory; and language comprehension and executive function. The main difference between the clusters related to degree of memory impairment. The composite score for memory between the clusters remained significantly different despite adjustment for illness duration and age of onset (p < 0.001).

Conclusions:

These data suggest clinical heterogeneity within an older group of people with AD. This may have implications for diagnosis, prognosis, response to currently available treatments, and the development of novel therapies.

Copyright

Corresponding author

Correspondence should be addressed to: Dr. Emma R.L.C. Vardy, Department of Older Peoples Medicine, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Road, High Heaton, Newcastle upon Tyne NE7 7DN, UK. Phone: +0191-248-1317; Fax: +0191-248-1301. Email: emma.vardy@ncl.ac.uk.

References

Hide All
Alexopoulos, G. S., Abrams, R. C., Young, R. C. and Shamoian, C. A. (1998). Cornell Scale for Depression in Dementia. Biological Psychiatry, 23, 271284.
Barber, R., Gholkar, A., Scheltens, P., Ballard, C., McKeith, I. G. and O’Brien, J. T. (1999). Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology, 52, 11531158.
Braak, H. and Braak, E. (1995). Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiology of Aging, 16, 271278, discussion; 278–284, review.
Coffey, C. E.et al. (1993). Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Archives of General Psychiatry, 50, 716.
Cogan, D. G. (1985). Visual disturbances with focal progressive dementing disease. American Journal of Ophthalmology, 100, 6872.
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A. and Gornbein, J. (1994). The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 23082314.
Davidson, Y. S.et al. (2011). TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathologica, 122, 703713. doi:10.1007/s00401-011-0879-y.
Dubois, B.et al. (2010). Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurology, 9, 11181127. doi:10.1016/S1474-4422(10)70223-4.
Galton, C. J., Patterson, K., Xuereb, J. H. and Hodges, J. R. (2000). Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain, 123, 484498.
Green, R. C., Goldstein, F. C., Mirra, S. S., Alazraki, N. P., Baxt, J. L. and Bakay, R. A. (1995). Slowly progressive apraxia in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 59, 312315.
Herrmann, N.et al. (1996). A validation study of the geriatric depression scale short form. International Journal of Geriatric Psychiatry, 11, 457460.
Johnson, J. K., Head, E., Kim, R., Starr, A. and Cotman, C. W. (1999). Clinical and pathological evidence for a frontal variant of Alzheimer disease. Archives of Neurology, 56, 12331239.
Killiany, R. J.et al. (2000). Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Annals of Neurology, 47, 430439.
Klugman, A., Marshall, J. and Tabet, N. (2009). Impact of cerebrovascular pathology on behavioural and neuropsychiatric symptoms in patients with Alzheimer's dementia: findings from a retrospective, naturalistic study. International Journal of Clinical Practice, 63, 10241030. doi:10.1111/j.1742-1241.2009.02079.x.
Koedam, E. L., Lauffer, V., van der Vlies, A. E., van der Flier, W. M., Scheltens, P. and Pijnenburg, Y. A. (2010). Early versus late-onset Alzheimer's disease: more than age alone. Journal of Alzheimer's Disease, 19, 14011408. doi:10.3233/JAD-2010-1337.
Korner, A.et al. (2006). The Geriatric Depression Scale and the Cornell Scale for Depression in Dementia. A validity study. Nordic Journal of Psychiatry, 60, 360364.
McKeith, I. G.et al. (2000). Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology, 54, 10501058.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939944.
McKhann, G. M.et al. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's and Dementia, 7, 263269. doi:10.1016/j.jalz.2011.03.005.
Murray, M. E., Graff-Radford, N. R., Ross, O. A., Petersen, R. C., Duara, R. and Dickson, D. W. (2011). Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurology, 10, 785796. doi:10.1016/S1474-4422(11)70156-9.
O’Brien, J. T., Eagger, S., Syed, G. M., Sahakian, B. J. and Levy, R. (1992). A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 55, 11821187.
O’Brien, J., Perry, R., Barber, R., Gholkar, A. and Thomas, A. (2000). The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms. Annals of the New York Academy of Sciences, 903, 482489.
O’Brien, J. T.et al. (2004). Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Archives of Neurology, 61, 919925.
Snowden, J. S.et al. (2007). Cognitive phenotypes in Alzheimer's disease and genetic risk. Cortex, 43, 835845.
Stopford, C. L., Snowden, J. S., Thompson, J. C. and Neary, D. (2008). Variability in cognitive presentation of Alzheimer's disease. Cortex, 44, 185195. doi:10.1016/j.cortex.2005.11.002.
Talbot, P. R., Snowden, J. S., Lloyd, J. J., Neary, D. and Testa, H. J. (1995). The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders. Journal of Neurology, 242, 579586.
van der Flier, W. M., Schoonenboom, S. N., Pijnenburg, Y. A., Fox, N. C. and Scheltens, P. (2006). The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology, 67, 526527.
Vardy, E. R.et al. (2012). Cognitive phenotypes in Alzheimer's disease and genetic variants in ACE and IDE. Neurobiology of Aging, 33, 1486 e1–2. doi:10.1016/j.neurobiolaging.2010.11.003.
Ward, J. (1963). Hierarchical grouping to optimize an objective function. Journal of the American Statistical Association, 58, 236244.
Watson, R., O’Brien, J. T., Barber, R. and Blamire, A. M. (2011). Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study. International Psychogeriatrics, 30, 19.
Williams, J. G., Huppert, F. A., Matthews, F. E. and Nickson, J. (2003). Performance and normative values of a concise neuropsychological test (CAMCOG) in an elderly population sample. International Journal of Geriatric Psychiatry, 18, 631644.
Yesavage, J. A.et al. (1982). Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research, 17, 3749.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed